Report cover image

Global Radiofrequency Ablation for Pain Management Market Growth (Status and Outlook) 2025-2031

Published Aug 06, 2025
Length 87 Pages
SKU # LPI20281551

Description

According to this study, the global Radiofrequency Ablation for Pain Management market size will reach US$ 640 million by 2031.

A radiofrequency ablation is a minimally invasive procedure that destroys the nerve fibers carrying pain signals to the brain. It can provide lasting relief for people with chronic pain, especially in the lower back, neck and arthritic joints. Radiofrequency ablation, also called rhizotomy, is a nonsurgical, minimally invasive procedure that uses heat to reduce or stop the transmission of pain. Radiofrequency waves ablate, or "burn," the nerve that is causing the pain, essentially eliminating the transmission of pain signals to the brain. This procedure is most commonly used to treat chronic pain and conditions such as arthritis of the spine (spondylosis) and sacroilitis. It is also used to treat neck, back, knee, pelvic and peripheral nerve pain. The benefits of radiofrequency ablation include avoiding surgery, immediate pain relief, little to no recovery time, decreased need for pain medication, improved function, and a quicker return to work and other activities.

The radiofrequency ablation (RFA) for pain management market is driven by the growing prevalence of chronic pain conditions, such as arthritis, lower back pain, and neuropathic disorders, especially among the aging population. As patients and healthcare systems increasingly seek minimally invasive, opioid-free alternatives to manage pain, RFA offers a cost-effective and long-lasting solution. Technological advancements, such as image-guided ablation and cooled RFA systems, are enhancing precision and outcomes, further accelerating adoption in both outpatient clinics and surgical centers.

Despite its benefits, the RFA market faces several challenges. High equipment costs and procedural expenses can limit accessibility, particularly in low- and middle-income regions. Additionally, reimbursement variability and strict regulatory pathways in some countries can slow adoption. Clinical limitations—such as varying effectiveness based on patient anatomy, nerve regeneration over time, and the need for repeat procedures—may also impact physician preference and patient satisfaction. Educating healthcare providers and patients on the benefits and limitations of RFA remains essential for sustained growth.

LPI (LP Information)' newest research report, the “Radiofrequency Ablation for Pain Management Industry Forecast” looks at past sales and reviews total world Radiofrequency Ablation for Pain Management sales in 2024, providing a comprehensive analysis by region and market sector of projected Radiofrequency Ablation for Pain Management sales for 2025 through 2031. With Radiofrequency Ablation for Pain Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiofrequency Ablation for Pain Management industry.

This Insight Report provides a comprehensive analysis of the global Radiofrequency Ablation for Pain Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radiofrequency Ablation for Pain Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiofrequency Ablation for Pain Management market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiofrequency Ablation for Pain Management and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiofrequency Ablation for Pain Management.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiofrequency Ablation for Pain Management market by product type, application, key players and key regions and countries.

Segmentation by Type:
RF Generators
Reusable Products
Disposable Products

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Avanos Medical
Stryker
Boston Scientific
Medtronic
Diros Technology

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

87 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Radiofrequency Ablation for Pain Management Market Size by Player
4 Radiofrequency Ablation for Pain Management by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Radiofrequency Ablation for Pain Management Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.